Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.

The global TB Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for TB Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of TB Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for TB Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the TB Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global TB Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for TB Vaccines sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of TB Vaccines Market Report

Report Metric	Details
Report Name	TB Vaccines Market
CAGR	5%
Segment by Type	Immunotherapeutic Vaccines Booster Vaccines Others
Segment by Application	Hospitals Private Clinics Research Institutes
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of TB Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TB Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the TB Vaccines Market report?

Ans: The main players in the TB Vaccines Market are Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal, Bio Pharma Limited, Statens Serum Institut

What are the Application segmentation covered in the TB Vaccines Market report?

Ans: The Applications covered in the TB Vaccines Market report are Hospitals, Private Clinics, Research Institutes

What are the Type segmentation covered in the TB Vaccines Market report?

Ans: The Types covered in the TB Vaccines Market report are Immunotherapeutic Vaccines, Booster Vaccines, Others

1 Study Coverage

1.1 TB Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global TB Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Immunotherapeutic Vaccines

1.2.3 Booster Vaccines

1.2.4 Others

1.3 Market by Application

1.3.1 Global TB Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Private Clinics

1.3.4 Research Institutes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global TB Vaccines Sales Estimates and Forecasts 2019-2030

2.2 Global TB Vaccines Revenue by Region

2.2.1 Global TB Vaccines Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global TB Vaccines Revenue by Region (2019-2024)

2.2.3 Global TB Vaccines Revenue by Region (2025-2030)

2.2.4 Global TB Vaccines Revenue Market Share by Region (2019-2030)

2.3 Global TB Vaccines Sales Estimates and Forecasts 2019-2030

2.4 Global TB Vaccines Sales by Region

2.4.1 Global TB Vaccines Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global TB Vaccines Sales by Region (2019-2024)

2.4.3 Global TB Vaccines Sales by Region (2025-2030)

2.4.4 Global TB Vaccines Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global TB Vaccines Sales by Manufacturers

3.1.1 Global TB Vaccines Sales by Manufacturers (2019-2024)

3.1.2 Global TB Vaccines Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TB Vaccines in 2023

3.2 Global TB Vaccines Revenue by Manufacturers

3.2.1 Global TB Vaccines Revenue by Manufacturers (2019-2024)

3.2.2 Global TB Vaccines Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by TB Vaccines Revenue in 2023

3.3 Global Key Players of TB Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global TB Vaccines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of TB Vaccines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of TB Vaccines, Product Offered and Application

3.8 Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global TB Vaccines Sales by Type

4.1.1 Global TB Vaccines Historical Sales by Type (2019-2024)

4.1.2 Global TB Vaccines Forecasted Sales by Type (2025-2030)

4.1.3 Global TB Vaccines Sales Market Share by Type (2019-2030)

4.2 Global TB Vaccines Revenue by Type

4.2.1 Global TB Vaccines Historical Revenue by Type (2019-2024)

4.2.2 Global TB Vaccines Forecasted Revenue by Type (2025-2030)

4.2.3 Global TB Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global TB Vaccines Price by Type

4.3.1 Global TB Vaccines Price by Type (2019-2024)

4.3.2 Global TB Vaccines Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global TB Vaccines Sales by Application

5.1.1 Global TB Vaccines Historical Sales by Application (2019-2024)

5.1.2 Global TB Vaccines Forecasted Sales by Application (2025-2030)

5.1.3 Global TB Vaccines Sales Market Share by Application (2019-2030)

5.2 Global TB Vaccines Revenue by Application

5.2.1 Global TB Vaccines Historical Revenue by Application (2019-2024)

5.2.2 Global TB Vaccines Forecasted Revenue by Application (2025-2030)

5.2.3 Global TB Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global TB Vaccines Price by Application

5.3.1 Global TB Vaccines Price by Application (2019-2024)

5.3.2 Global TB Vaccines Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada TB Vaccines Market Size by Type

6.1.1 US & Canada TB Vaccines Sales by Type (2019-2030)

6.1.2 US & Canada TB Vaccines Revenue by Type (2019-2030)

6.2 US & Canada TB Vaccines Market Size by Application

6.2.1 US & Canada TB Vaccines Sales by Application (2019-2030)

6.2.2 US & Canada TB Vaccines Revenue by Application (2019-2030)

6.3 US & Canada TB Vaccines Market Size by Country

6.3.1 US & Canada TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada TB Vaccines Sales by Country (2019-2030)

6.3.3 US & Canada TB Vaccines Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe TB Vaccines Market Size by Type

7.1.1 Europe TB Vaccines Sales by Type (2019-2030)

7.1.2 Europe TB Vaccines Revenue by Type (2019-2030)

7.2 Europe TB Vaccines Market Size by Application

7.2.1 Europe TB Vaccines Sales by Application (2019-2030)

7.2.2 Europe TB Vaccines Revenue by Application (2019-2030)

7.3 Europe TB Vaccines Market Size by Country

7.3.1 Europe TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe TB Vaccines Sales by Country (2019-2030)

7.3.3 Europe TB Vaccines Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China TB Vaccines Market Size

8.1.1 China TB Vaccines Sales (2019-2030)

8.1.2 China TB Vaccines Revenue (2019-2030)

8.2 China TB Vaccines Market Size by Application

8.2.1 China TB Vaccines Sales by Application (2019-2030)

8.2.2 China TB Vaccines Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia TB Vaccines Market Size by Type

9.1.1 Asia TB Vaccines Sales by Type (2019-2030)

9.1.2 Asia TB Vaccines Revenue by Type (2019-2030)

9.2 Asia TB Vaccines Market Size by Application

9.2.1 Asia TB Vaccines Sales by Application (2019-2030)

9.2.2 Asia TB Vaccines Revenue by Application (2019-2030)

9.3 Asia TB Vaccines Sales by Region

9.3.1 Asia TB Vaccines Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia TB Vaccines Revenue by Region (2019-2030)

9.3.3 Asia TB Vaccines Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America TB Vaccines Market Size by Type

10.1.1 Middle East, Africa and Latin America TB Vaccines Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America TB Vaccines Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America TB Vaccines Market Size by Application

10.2.1 Middle East, Africa and Latin America TB Vaccines Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America TB Vaccines Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America TB Vaccines Sales by Country

10.3.1 Middle East, Africa and Latin America TB Vaccines Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America TB Vaccines Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America TB Vaccines Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Merck & Co.,Inc

11.1.1 Merck & Co.,Inc Company Information

11.1.2 Merck & Co.,Inc Overview

11.1.3 Merck & Co.,Inc TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Merck & Co.,Inc TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck & Co.,Inc Recent Developments

11.2 Sanofi Pasteur

11.2.1 Sanofi Pasteur Company Information

11.2.2 Sanofi Pasteur Overview

11.2.3 Sanofi Pasteur TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Sanofi Pasteur TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Sanofi Pasteur Recent Developments

11.3 Japan BCG Laboratory

11.3.1 Japan BCG Laboratory Company Information

11.3.2 Japan BCG Laboratory Overview

11.3.3 Japan BCG Laboratory TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Japan BCG Laboratory TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Japan BCG Laboratory Recent Developments

11.4 China National Biotec Group

11.4.1 China National Biotec Group Company Information

11.4.2 China National Biotec Group Overview

11.4.3 China National Biotec Group TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 China National Biotec Group TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 China National Biotec Group Recent Developments

11.5 Serum Institute

11.5.1 Serum Institute Company Information

11.5.2 Serum Institute Overview

11.5.3 Serum Institute TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Serum Institute TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Serum Institute Recent Developments

11.6 India Pvt. Ltd

11.6.1 India Pvt. Ltd Company Information

11.6.2 India Pvt. Ltd Overview

11.6.3 India Pvt. Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 India Pvt. Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 India Pvt. Ltd Recent Developments

11.7 InterVax Ltd

11.7.1 InterVax Ltd Company Information

11.7.2 InterVax Ltd Overview

11.7.3 InterVax Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 InterVax Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 InterVax Ltd Recent Developments

11.8 GreenSignal

11.8.1 GreenSignal Company Information

11.8.2 GreenSignal Overview

11.8.3 GreenSignal TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 GreenSignal TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 GreenSignal Recent Developments

11.9 Bio Pharma Limited

11.9.1 Bio Pharma Limited Company Information

11.9.2 Bio Pharma Limited Overview

11.9.3 Bio Pharma Limited TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Bio Pharma Limited TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Bio Pharma Limited Recent Developments

11.10 Statens Serum Institut

11.10.1 Statens Serum Institut Company Information

11.10.2 Statens Serum Institut Overview

11.10.3 Statens Serum Institut TB Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Statens Serum Institut TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Statens Serum Institut Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 TB Vaccines Industry Chain Analysis

12.2 TB Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 TB Vaccines Production Mode & Process

12.4 TB Vaccines Sales and Marketing

12.4.1 TB Vaccines Sales Channels

12.4.2 TB Vaccines Distributors

12.5 TB Vaccines Customers

13 Market Dynamics

13.1 TB Vaccines Industry Trends

13.2 TB Vaccines Market Drivers

13.3 TB Vaccines Market Challenges

13.4 TB Vaccines Market Restraints

14 Key Findings in The Global TB Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Merck& Co. Inc

Sanofi Pasteur

Japan BCG Laboratory

China National Biotec Group

Statens Serum Institut

List of Tables

Table 1. Global TB Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Immunotherapeutic Vaccines

Table 3. Major Manufacturers of Booster Vaccines

Table 4. Major Manufacturers of Others

Table 5. Global TB Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global TB Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global TB Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global TB Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global TB Vaccines Revenue Market Share by Region (2019-2024)

Table 10. Global TB Vaccines Revenue Market Share by Region (2025-2030)

Table 11. Global TB Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global TB Vaccines Sales by Region (2019-2024) & (K Units)

Table 13. Global TB Vaccines Sales by Region (2025-2030) & (K Units)

Table 14. Global TB Vaccines Sales Market Share by Region (2019-2024)

Table 15. Global TB Vaccines Sales Market Share by Region (2025-2030)

Table 16. Global TB Vaccines Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global TB Vaccines Sales Share by Manufacturers (2019-2024)

Table 18. Global TB Vaccines Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global TB Vaccines Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of TB Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. TB Vaccines Price by Manufacturers 2019-2024 (USD/Unit)

Table 22. Global TB Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global TB Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in TB Vaccines as of 2023)

Table 24. Global Key Manufacturers of TB Vaccines, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of TB Vaccines, Product Offered and Application

Table 26. Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 29. Global TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 30. Global TB Vaccines Sales Share by Type (2019-2024)

Table 31. Global TB Vaccines Sales Share by Type (2025-2030)

Table 32. Global TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global TB Vaccines Revenue Share by Type (2019-2024)

Table 35. Global TB Vaccines Revenue Share by Type (2025-2030)

Table 36. TB Vaccines Price by Type (2019-2024) & (USD/Unit)

Table 37. Global TB Vaccines Price Forecast by Type (2025-2030) & (USD/Unit)

Table 38. Global TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 39. Global TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 40. Global TB Vaccines Sales Share by Application (2019-2024)

Table 41. Global TB Vaccines Sales Share by Application (2025-2030)

Table 42. Global TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global TB Vaccines Revenue Share by Application (2019-2024)

Table 45. Global TB Vaccines Revenue Share by Application (2025-2030)

Table 46. TB Vaccines Price by Application (2019-2024) & (USD/Unit)

Table 47. Global TB Vaccines Price Forecast by Application (2025-2030) & (USD/Unit)

Table 48. US & Canada TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada TB Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 61. Europe TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 62. Europe TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 63. Europe TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 66. Europe TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 67. Europe TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe TB Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 73. Europe TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 74. China TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 75. China TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 76. China TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 77. China TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 78. China TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 79. China TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 80. China TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 81. China TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 83. Asia TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 84. Asia TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 87. Asia TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 88. Asia TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia TB Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia TB Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia TB Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia TB Vaccines Sales by Region (2019-2024) & (K Units)

Table 94. Asia TB Vaccines Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America TB Vaccines Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America TB Vaccines Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America TB Vaccines Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America TB Vaccines Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America TB Vaccines Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America TB Vaccines Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America TB Vaccines Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America TB Vaccines Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America TB Vaccines Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America TB Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America TB Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America TB Vaccines Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America TB Vaccines Sales by Country (2025-2030) & (K Units)

Table 108. Merck & Co.,Inc Company Information

Table 109. Merck & Co.,Inc Description and Major Businesses

Table 110. Merck & Co.,Inc TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 111. Merck & Co.,Inc TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Merck & Co.,Inc Recent Developments

Table 113. Sanofi Pasteur Company Information

Table 114. Sanofi Pasteur Description and Major Businesses

Table 115. Sanofi Pasteur TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 116. Sanofi Pasteur TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Sanofi Pasteur Recent Developments

Table 118. Japan BCG Laboratory Company Information

Table 119. Japan BCG Laboratory Description and Major Businesses

Table 120. Japan BCG Laboratory TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 121. Japan BCG Laboratory TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Japan BCG Laboratory Recent Developments

Table 123. China National Biotec Group Company Information

Table 124. China National Biotec Group Description and Major Businesses

Table 125. China National Biotec Group TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 126. China National Biotec Group TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. China National Biotec Group Recent Developments

Table 128. Serum Institute Company Information

Table 129. Serum Institute Description and Major Businesses

Table 130. Serum Institute TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 131. Serum Institute TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Serum Institute Recent Developments

Table 133. India Pvt. Ltd Company Information

Table 134. India Pvt. Ltd Description and Major Businesses

Table 135. India Pvt. Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 136. India Pvt. Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. India Pvt. Ltd Recent Developments

Table 138. InterVax Ltd Company Information

Table 139. InterVax Ltd Description and Major Businesses

Table 140. InterVax Ltd TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 141. InterVax Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. InterVax Ltd Recent Developments

Table 143. GreenSignal Company Information

Table 144. GreenSignal Description and Major Businesses

Table 145. GreenSignal TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 146. GreenSignal TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. GreenSignal Recent Developments

Table 148. Bio Pharma Limited Company Information

Table 149. Bio Pharma Limited Description and Major Businesses

Table 150. Bio Pharma Limited TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 151. Bio Pharma Limited TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Bio Pharma Limited Recent Developments

Table 153. Statens Serum Institut Company Information

Table 154. Statens Serum Institut Description and Major Businesses

Table 155. Statens Serum Institut TB Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 156. Statens Serum Institut TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Statens Serum Institut Recent Developments

Table 158. Key Raw Materials Lists

Table 159. Raw Materials Key Suppliers Lists

Table 160. TB Vaccines Distributors List

Table 161. TB Vaccines Customers List

Table 162. TB Vaccines Market Trends

Table 163. TB Vaccines Market Drivers

Table 164. TB Vaccines Market Challenges

Table 165. TB Vaccines Market Restraints

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. TB Vaccines Product Picture

Figure 2. Global TB Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global TB Vaccines Market Share by Type in 2023 & 2030

Figure 4. Immunotherapeutic Vaccines Product Picture

Figure 5. Booster Vaccines Product Picture

Figure 6. Others Product Picture

Figure 7. Global TB Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global TB Vaccines Market Share by Application in 2023 & 2030

Figure 9. Hospitals

Figure 10. Private Clinics

Figure 11. Research Institutes

Figure 12. TB Vaccines Report Years Considered

Figure 13. Global TB Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global TB Vaccines Revenue 2019-2030 (US$ Million)

Figure 15. Global TB Vaccines Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global TB Vaccines Revenue Market Share by Region (2019-2030)

Figure 17. Global TB Vaccines Sales 2019-2030 ((K Units)

Figure 18. Global TB Vaccines Sales Market Share by Region (2019-2030)

Figure 19. US & Canada TB Vaccines Sales YoY (2019-2030) & (K Units)

Figure 20. US & Canada TB Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe TB Vaccines Sales YoY (2019-2030) & (K Units)

Figure 22. Europe TB Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China TB Vaccines Sales YoY (2019-2030) & (K Units)

Figure 24. China TB Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) TB Vaccines Sales YoY (2019-2030) & (K Units)

Figure 26. Asia (excluding China) TB Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America TB Vaccines Sales YoY (2019-2030) & (K Units)

Figure 28. Middle East, Africa and Latin America TB Vaccines Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The TB Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of TB Vaccines in the World: Market Share by TB Vaccines Revenue in 2023

Figure 31. Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global TB Vaccines Sales Market Share by Type (2019-2030)

Figure 33. Global TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 34. Global TB Vaccines Sales Market Share by Application (2019-2030)

Figure 35. Global TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada TB Vaccines Sales Market Share by Type (2019-2030)

Figure 37. US & Canada TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada TB Vaccines Sales Market Share by Application (2019-2030)

Figure 39. US & Canada TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada TB Vaccines Revenue Share by Country (2019-2030)

Figure 41. US & Canada TB Vaccines Sales Share by Country (2019-2030)

Figure 42. U.S. TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 43. Canada TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 44. Europe TB Vaccines Sales Market Share by Type (2019-2030)

Figure 45. Europe TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 46. Europe TB Vaccines Sales Market Share by Application (2019-2030)

Figure 47. Europe TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 48. Europe TB Vaccines Revenue Share by Country (2019-2030)

Figure 49. Europe TB Vaccines Sales Share by Country (2019-2030)

Figure 50. Germany TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 51. France TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 53. Italy TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 54. Russia TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 55. China TB Vaccines Sales Market Share by Type (2019-2030)

Figure 56. China TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 57. China TB Vaccines Sales Market Share by Application (2019-2030)

Figure 58. China TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 59. Asia TB Vaccines Sales Market Share by Type (2019-2030)

Figure 60. Asia TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 61. Asia TB Vaccines Sales Market Share by Application (2019-2030)

Figure 62. Asia TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 63. Asia TB Vaccines Revenue Share by Region (2019-2030)

Figure 64. Asia TB Vaccines Sales Share by Region (2019-2030)

Figure 65. Japan TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 69. India TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America TB Vaccines Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America TB Vaccines Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America TB Vaccines Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America TB Vaccines Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America TB Vaccines Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America TB Vaccines Sales Share by Country (2019-2030)

Figure 76. Brazil TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 79. Israel TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries TB Vaccines Revenue (2019-2030) & (US$ Million)

Figure 81. TB Vaccines Value Chain

Figure 82. TB Vaccines Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions